PRPL notified of Nasdaq bid-price deficiency; cure window to May 4, 2026

Rhea-AI Filing Summary

Purple Innovation (PRPL) reported a Nasdaq compliance notice. The company fell out of compliance with Nasdaq Listing Rule 5450(a)(1) after its Class A common stock’s closing bid stayed below $1.00 per share for 30 consecutive business days. The notice has no immediate effect on trading on the Nasdaq Global Select Market.

Purple has 180 calendar days, until May 4, 2026, to regain compliance by achieving a closing bid of at least $1.00 for ten consecutive business days. If it does not regain compliance by then, the company may seek an additional 180-day period by transferring to the Nasdaq Capital Market, subject to meeting that market’s initial standards (other than bid price) and notifying Nasdaq it intends to cure the deficiency, which may include a reverse stock split. If compliance is not restored or a transfer is not permitted, Nasdaq could move to delist, and the company could appeal.

Insights

Equity listings & market structure analyst

Nasdaq bid-price deficiency notice; 180-day window to cure.

Purple Innovation disclosed noncompliance with Nasdaq’s $1.00 minimum bid under Rule 5450(a)(1) after 30 consecutive business days below the threshold. Trading continues on the Nasdaq Global Select Market with no immediate impact.

The company has 180 calendar days, until May 4, 2026, to post at least ten consecutive business days with a closing bid at or above $1.00. If unsuccessful, it may transfer to the Nasdaq Capital Market for an additional 180-day period, provided it meets other initial listing standards and indicates it may use a reverse split to cure.

Actual outcomes depend on share price performance and any corporate actions the company elects. If compliance is not achieved and no transfer is permitted, Nasdaq could proceed to delist, which the company could appeal.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice or transferred its listing to a different exchange.

FAQ

What did Purple Innovation (PRPL) disclose in this 8-K?

PRPL received a Nasdaq notice for not meeting the $1.00 minimum bid price for 30 consecutive business days under Rule 5450(a)(1).

What is PRPL’s deadline to regain Nasdaq bid-price compliance?

PRPL has 180 calendar days, until May 4, 2026, to regain compliance.

How can PRPL regain compliance with Nasdaq’s minimum bid price?

Its closing bid must be at least $1.00 per share for ten consecutive business days within the 180-day period.

Does the notice immediately affect PRPL’s listing?

No. The notice has no immediate effect on the listing or trading of PRPL’s Class A common stock.

What happens if PRPL doesn’t regain compliance by May 4, 2026?

PRPL may seek an additional 180 days by transferring to the Nasdaq Capital Market if it meets required standards and signals intent to cure.

Could PRPL face delisting from Nasdaq?

If compliance is not restored and no transfer is permitted, Nasdaq could move to delist; PRPL could appeal such a determination.

What options might PRPL consider to address the deficiency?

The company will monitor its stock price and may consider options including a reverse stock split as described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 11/06/2025 - 04:06 PM Learn about SEC filing dates

false 0001643953 0001643953 2025-11-05 2025-11-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 5, 2025

Purple Innovation, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware		001-37523		47-4078206
(State of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

4100 North Chapel Ridge Rd., Suite 200
Lehi, Utah		84048
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (801) 756-2600

N/A 

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share		PRPL		The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§240.12b–2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 3.01. NOTICE OF DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING.

On November 5, 2025, Purple Innovation, Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), as the closing bid price of the Company’s common stock has been below the required minimum of $1.00 per share for 30 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s Class A common stock on The Nasdaq Global Select Market.

The Company has 180 calendar days, or until May 4, 2026, to regain compliance with the minimum bid price requirement in Nasdaq Listing Rule 5450(a)(1). To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00 per share for a minimum of ten consecutive business days during this 180-calendar day compliance period. In the event the Company does not regain compliance with the minimum bid price requirement by May 4, 2026, the Company may be eligible for an additional 180-calendar day compliance period if it elects to transfer to The Nasdaq Capital Market to take advantage of the additional compliance period offered on that market. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum bid price requirement, and would need to provide written notice of its intention to cure the bid price deficiency during the second compliance period by effecting a reverse stock split if necessary. In the event the Company fails to regain compliance or is not permitted to transfer to The Nasdaq Capital Market before the initial compliance period expires, the Company will receive a written notification from Nasdaq that its common stock is subject to delisting. If the Company were to receive such a notification, the Company could appeal Nasdaq’s determination to delist its common stock, but there can be no assurance Nasdaq would grant the Company’s request for continued listing.

The Company intends to actively monitor the bid price of its common stock and will consider available options to regain compliance with the minimum bid price requirement. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rule 5450(a)(1) or will otherwise be in compliance with other Nasdaq listing requirements.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 6, 2025	PURPLE INNOVATION, INC.
	By:	/s/ Todd Vogensen
		Todd Vogensen
		Chief Financial Officer

2